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A process has been developed that can
confer novel properties, such as metal re-
sistance, to a host bacterium. This same
process can also be used to produce
RNAs and peptides that have novel prop-
erties, such as the ability to bind particu-
lar compounds. It is inherent in the
method that the peptide or RNA will be-
have as expected in the target organism.
Plasmid-born mini-gene libraries coding
for either a population of combinatorial
peptides or stable, artificial RNAs carry-
ing random inserts are produced. These
libraries, which have no bias towards any
biological function, are used to trans-
form the organism of interest and to
serve as an initial source of genetic varia-
tion for stress-driven evolution. 
The transformed bacteria are propa-
gated under selective pressure in order
to obtain variants with the desired prop-
erties. The process is highly distinct
from in vitro methods because the vari-
ants are selected in the context of the
cell while it is experiencing stress.
Hence, the selected peptide or RNA will,
by definition, work as expected in the
target cell as the cell adapts to its pres-
ence during the selection process. Once
the novel gene, which produces the
sought phenotype, is obtained, it can be
transferred to the main genome to in-
crease the genetic stability in the organ-
ism. Alternatively, the cell line can be
used to produce novel RNAs or peptides
with selectable properties in large quan-
tity for separate purposes. The system al-
lows for easy, large-scale purification of
the RNAs or peptide products.
Stress-Driven Selection of Novel Phenotypes
A methodology allows the experimental design of novel peptides and RNAs 
that have desired properties.
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The aim of tissue engineering (TE) is
to restore tissue and organ functions
with minimal host rejection. TE is seen
as a future solution to solve the crisis of
donor organs for transplant, which faces
a shortage expected only to increase in
the future. In this innovation, a flexible
and configurable scaffold has been con-
ceived that mechanically stresses cells
that are seeded on it, stimulating them
to increased growth. 
The influence of mechanical stress/
loading on cell growth has been ob-
served on all forms of cells. For exam-
ple, for cartilages, studies in animals, tis-
sue explants, and engineered tissue
scaffolds have all shown that cartilage
cells (chondrocytes) modify their extra-
cellular matrix in response to loading.
The chondrocyte EMC production re-
sponse to dynamics of the physical envi-
ronment (in vivo cartilage develop-
ment) illustrates a clear benefit (better
growth) when stressed. It has been
shown that static and dynamic compres-
sion regulates PRG4 biosynthesis by car-
tilage explants. 
Mechanical tissue stimulation is bene-
ficial and (flexible) scaffolds with mov-
able components, which are able to in-
duce mechanical stimulation, offer
advantages over the fixed, rigid scaffold
design. In addition to improved cell
growth from physical/mechanical stimu-
lation, additional benefits include the
ability to increase in size while preserv-
ing shape, or changing shape.
By making scaffolds flexible, allowing
relative movement between their com-
ponents, adding sensing (e.g., for de-
tecting response of cells to drug release
and to mechanical actions), building
controls for drug release and move-
ment, and building even simple algo-
rithms for mapping sensing to action,
these structures can actually be made
into biocompatible and biodegradable
robots. Treating them as robots is a per-
spective shift that may offer advantages
in the design and exploitation of these
structures of the future.
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Biocompatible and biodegradable smart scaffolds could reconfigure their shape and size to
accommodate organ development. 
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e.g. cancer. The chief advantages of the
proposed methods are their speed, ease,
reliability, and capacity to select individ-
ual cells from a tissue slice population
with a higher degree of purity and speci-
ficity. The result is the extracted DNA
can be biochemically analyzed with a
higher degree of diagnostic accuracy, as
the isolated sub-sample would not be di-
luted by unwanted material from the
ambient tissue. In comparison to other
techniques, the proposed methods
would combine high specificity with
high speed. 
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